SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-21-014463
Filing Date
2021-03-22
Accepted
2021-03-22 06:05:29
Documents
91
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K fprx-10k_20201231.htm   iXBRL 10-K 5542305
2 EX-23.1 fprx-ex231_125.htm EX-23.1 6114
3 EX-31.1 fprx-ex311_47.htm EX-31.1 18758
4 EX-31.2 fprx-ex312_46.htm EX-31.2 18784
5 EX-32.1 fprx-ex321_44.htm EX-32.1 6792
6 EX-32.2 fprx-ex322_45.htm EX-32.2 6825
7 GRAPHIC gasym3jgpjnx000001.jpg GRAPHIC 61516
  Complete submission text file 0001564590-21-014463.txt   16735235

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA fprx-20201231.xsd EX-101.SCH 74781
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fprx-20201231_cal.xml EX-101.CAL 80158
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fprx-20201231_def.xml EX-101.DEF 299183
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE fprx-20201231_lab.xml EX-101.LAB 607806
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fprx-20201231_pre.xml EX-101.PRE 492882
13 EXTRACTED XBRL INSTANCE DOCUMENT fprx-10k_20201231_htm.xml XML 3411143
Mailing Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS, INC. (Filer) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36070 | Film No.: 21759780
SIC: 2834 Pharmaceutical Preparations